Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

NOIP: HEAL Initiative Whole Joint Health Program

National Institutes of Health

Note: This is a Forecasted Opportunity.

The National Center for Complementary and Integrative Health (NCCIH) plans to publish a Notice of Funding Opportunity (NOFO) that will support a phased mechanistic clinical research program focusing on understudied biological mechanisms that drive joint pain. The initiative responds to priorities identified in the 2023 HEAL Whole Joint Pain Workshop and supports the broader goals of the NIH Helping to End Addiction Long-term (HEAL) Initiative and the Make America Healthy Again vision by advancing safe, non-addictive, and prevention-oriented approaches to chronic pain.

Joint pain affects nearly half of adults in the United States. Many current treatments provide incomplete or temporary relief, informed by clinical trials that focus on joint structures such as bone or cartilage in isolation, without addressing contributions from additional tissues comprising the “whole joint”. New advances in imaging, biomechanics, tissue-specific omics, electrophysiology, and digital health tools now allow for a more complete evaluation of the whole joint, including periarticular tissues such as muscle, adipose, ligaments, tendons, and fascia.

The phased projects supported by this program will first identify and validate multi-tissue mechanisms underlying joint pain, then test non-pharmacological or multimodal interventions that directly target these mechanisms. Please note that while applications can specify the length of time for each of the following study phases, the total project length cannot exceed 5 years:

Phase 1 (2 to 3 years): Projects will identify multisystem mechanisms that include signals from periarticular tissues (e.g., muscles, adipose, and connective tissues including ligaments, tendons, or fascia) and their potential interactions with articular tissues (e.g., bone, synovium, cartilage) or the peripheral nervous system that contribute to joint pain and pathophysiology. Studies may incorporate imaging, biomarker profiling, neuromuscular assessment, behavioral or environmental factors, and other multimodal approaches that meet or exceed NIH standards for rigor and reproducibility.

Phase 2 (2 to 3 years): Successful phase 1 projects will receive additional funding to test the impact that non-pharmacological and/or multimodal interventions have on the identified multi-tissue mechanisms, to define how these interventions work to correct pathophysiology, aid healing, and resolve pain in the joint. Proposed interventions may include physical therapy, mind-body approaches, biomechanical strategies, or integrated multimodal treatments.

Estimated Post Date:

May 31, 2026

Estimated Application Due Date:

Oct 07, 2026

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Medical - Translational

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: National Institutes of Health

Sponsor Type: Government/Federal

Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity